TP53 and head and neck squamous cell carcinoma: By conducting ROS detection, we observed the rise of ROS after PYGL knock-down (Fig. 7G and H), which illustrated that PYGL probably suppressed TP53 through ROS consumption mediated by GSH metabolism and ultimately promoted the evolvement of HNSCC.